How a tiny seaweed-dwelling animal led this East Bay startup to HIV, cancer

The synthetic sibling of an expensive molecule harvested from a tiny seaweed-dwelling animal could lead to next-generation cancer drugs or a functional cure for HIV, an East Bay company believes. Those lofty targets are years in the distance for startup BryoLogyx Inc., but the company said it will expand preclinical testing next year with synthetic bryostatin, eyeing more investor and scientific interest. BryoLogyx bought exclusive rights to synthetic bryostatin and its potential offshoot s from…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news